BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2179470)

  • 21. Morphologic changes and immunohistochemical localization of adenosine deaminase in tissues of rats given injections of 2'-deoxycoformycin.
    Checkik BE; Perets A; SenGupta S; Fernandes B
    J Natl Cancer Inst; 1983 Nov; 71(5):999-1010. PubMed ID: 6358608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine deaminase and histidine decarboxylase coexist in certain neurons of the rat brain.
    Patel BT; Tudball N; Wada H; Watanabe T
    Neurosci Lett; 1986 Jan; 63(2):185-9. PubMed ID: 3513053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine-deaminase-associated immunodeficiency. I. Differential sensitivities of lymphocyte subpopulations exposed to 2-deoxycoformycin in vivo.
    Bagasra O; Howeedy A; Pomerantz RJ
    Clin Exp Immunol; 1992 Jun; 88(3):383-8. PubMed ID: 1535036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of adenosine deaminase inhibition on active uptake and metabolism of adenosine in astrocytes in primary cultures.
    Matz H; Hertz L
    Brain Res; 1990 May; 515(1-2):168-72. PubMed ID: 2357554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine deaminase gene amplification in deoxycoformycin-resistant mammalian cells.
    Rowland P; Pfeilsticker J; Hoffee PA
    Arch Biochem Biophys; 1985 Jun; 239(2):396-403. PubMed ID: 3873908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of insulin-dependent diabetes mellitus by 2'-deoxycoformycin in the BB Wistar rat.
    Thliveris JA; Begleiter A; Kobrinsky NL; Verburg L; Dean HJ; Johnston JB
    Biochem Pharmacol; 1993 Sep; 46(6):1071-5. PubMed ID: 8216350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome anomalies associated with amplification of the adenosine deaminase gene (ADA) in rat hepatoma cells.
    Rowland P; Chiang J; Jargiello-Jarrett P; Hoffee PA
    Cytogenet Cell Genet; 1986; 41(3):136-44. PubMed ID: 3485513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lymphocyte activity of adenosine deaminase and enzymes of AMP metabolism in mammary carcinogenesis: the effect of thymostimulin.
    Grinevich YuA ; Umansky VYu ; Kamenets LYa ; Nikolsky IS
    Neoplasma; 1984; 31(1):21-9. PubMed ID: 6322026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse.
    Knudsen TB; Winters RS; Otey SK; Blackburn MR; Airhart MJ; Church JK; Skalko RG
    Teratology; 1992 Jan; 45(1):91-103. PubMed ID: 1731400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An enzymatic kinetic method for the determination of 2'-deoxycoformycin in biological fluids.
    Staubus AE; Weinrib AB; Malspeis L
    Biochem Pharmacol; 1984 May; 33(10):1633-7. PubMed ID: 6610419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
    Spiers AS
    Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.
    Kutryb-Zajac B; Koszalka P; Mierzejewska P; Bulinska A; Zabielska MA; Brodzik K; Skrzypkowska A; Zelazek L; Pelikant-Malecka I; Slominska EM; Smolenski RT
    J Cell Mol Med; 2018 Dec; 22(12):5939-5954. PubMed ID: 30291675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose deoxycoformycin in lymphoid malignancy.
    Grever MR; Leiby JM; Kraut EH; Wilson HE; Neidhart JA; Wall RL; Balcerzak SP
    J Clin Oncol; 1985 Sep; 3(9):1196-201. PubMed ID: 2993534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors.
    Golembiowska K; White TD; Sawynok J
    Brain Res; 1995 Nov; 699(2):315-20. PubMed ID: 8616636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
    Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
    Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of benzodiazepines on the activity of AMP deaminase and adenosine deaminase in rat brain tissue in vivo].
    Korotkina RN; Papin AA; Karelin AA
    Biull Eksp Biol Med; 1986 Jul; 102(7):41-4. PubMed ID: 2873849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.
    Gandhi V; Chen W; Ayres M; Rhie JK; Madden TL; Newman RA
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):85-94. PubMed ID: 12172971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine and cyclic AMP in rat cerebral cortical slices: effects of adenosine uptake inhibitors and adenosine deaminase inhibitors.
    Nimit Y; Skolnick P; Daly JW
    J Neurochem; 1981 Mar; 36(3):908-12. PubMed ID: 6259294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.